APO Research
Talk to an analyst

APO RESEARCH · REPORT

Track-and-Trace and Serialization for Drug

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Track-and-Trace and Serialization for Drug Market Analysis and Forecast 2026-2032

12 August 2026172 pages

Choose your research edition.

Industry ResearchTrack-and-Trace and Serialization for Drug Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Track-and-Trace and Serialization for Drug Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Track-and-Trace and Serialization for Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Track-and-Trace and Serialization for Drug Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Track-and-Trace and Serialization for Drug Market Analysis and Forecast 2026-2032172 pages · $4,950 USD

Market perspective

The global Track-and-Trace and Serialization for Drug market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Track-and-Trace and Serialization for Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Track-and-Trace and Serialization for Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Track-and-Trace and Serialization for Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Track-and-Trace and Serialization for Drug is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Track-and-Trace and Serialization for Drug include Bosch Packaging, SAP, Axway, Xyntec Inc, SoftGroup, TraceLink and Infosys, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Track-and-Trace and Serialization for Drug, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Track-and-Trace and Serialization for Drug, also provides the revenue of main regions and countries. Of the upcoming market potential for Track-and-Trace and Serialization for Drug, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Track-and-Trace and Serialization for Drug revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Track-and-Trace and Serialization for Drug market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Track-and-Trace and Serialization for Drug revenue, projected growth trends, production technology, application and end-user industry.

Track-and-Trace and Serialization for Drug Segment by Company

Bosch Packaging

SAP

Axway

Xyntec Inc

SoftGroup

TraceLink

Infosys

Track-and-Trace and Serialization for Drug Segment by Type

Cloud-based

On-premise

Track-and-Trace and Serialization for Drug Segment by Application

Biopharmaceutical

Chemical Pharmaceutical

Track-and-Trace and Serialization for Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Track-and-Trace and Serialization for Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Track-and-Trace and Serialization for Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Track-and-Trace and Serialization for Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Track-and-Trace and Serialization for Drug in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Track-and-Trace and Serialization for Drug company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Track-and-Trace and Serialization for Drug revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Cloud-based Major Player Table 3. On-premise Major Player Table 4. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Biopharmaceutical Major Player Table 6. Chemical Pharmaceutical Major Player Table 7. Track-and-Trace and Serialization for Drug Industry Trends Table 8. Track-and-Trace and Serialization for Drug Industry Drivers Table 9. Track-and-Trace and Serialization for Drug Industry Opportunities and Challenges Table 10. Track-and-Trace and Serialization for Drug Industry Restraints Table 11. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 12. Global Track-and-Trace and Serialization for Drug Market Size by Region (2021-2026) & (US$ Million) Table 13. Global Track-and-Trace and Serialization for Drug Market Share by Region (2021-2026) Table 14. Global Track-and-Trace and Serialization for Drug Market Size by Region (2027-2032) & (US$ Million) Table 15. Global Track-and-Trace and Serialization for Drug Market Share by Region (2027-2032) Table 16. Global Track-and-Trace and Serialization for Drug Revenue by Players (US$ Million) & (2021-2026) Table 17. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Players (2021-2026) Table 18. Global Track-and-Trace and Serialization for Drug Key Players Ranking, 2024 VS 2025 VS 2026 Table 19. Global Track-and-Trace and Serialization for Drug Key Players Headquarters & Area Served Table 20. Global Track-and-Trace and Serialization for Drug Players, Product Type & Application Table 21. Global Track-and-Trace and Serialization for Drug Players Establishment Date Table 22. Global Players Market Concentration Ratio (CR5 and HHI) Table 23. Global Track-and-Trace and Serialization for Drug by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 24. Global Track-and-Trace and Serialization for Drug Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026) & (US$ Million) Table 26. Global Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032) & (US$ Million) Table 27. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2021-2026) Table 28. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2027-2032) Table 29. Global Track-and-Trace and Serialization for Drug Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026) & (US$ Million) Table 31. Global Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032) & (US$ Million) Table 32. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2021-2026) Table 33. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2027-2032) Table 34. Bosch Packaging Company Information Table 35. Bosch Packaging Business Overview Table 36. Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 37. Bosch Packaging Track-and-Trace and Serialization for Drug Product Portfolio Table 38. Bosch Packaging Recent Development Table 39. SAP Company Information Table 40. SAP Business Overview Table 41. SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 42. SAP Track-and-Trace and Serialization for Drug Product Portfolio Table 43. SAP Recent Development Table 44. Axway Company Information Table 45. Axway Business Overview Table 46. Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 47. Axway Track-and-Trace and Serialization for Drug Product Portfolio Table 48. Axway Recent Development Table 49. Xyntec Inc Company Information Table 50. Xyntec Inc Business Overview Table 51. Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 52. Xyntec Inc Track-and-Trace and Serialization for Drug Product Portfolio Table 53. Xyntec Inc Recent Development Table 54. SoftGroup Company Information Table 55. SoftGroup Business Overview Table 56. SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 57. SoftGroup Track-and-Trace and Serialization for Drug Product Portfolio Table 58. SoftGroup Recent Development Table 59. TraceLink Company Information Table 60. TraceLink Business Overview Table 61. TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 62. TraceLink Track-and-Trace and Serialization for Drug Product Portfolio Table 63. TraceLink Recent Development Table 64. Infosys Company Information Table 65. Infosys Business Overview Table 66. Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin (US$ Million) & (2021-2026) Table 67. Infosys Track-and-Trace and Serialization for Drug Product Portfolio Table 68. Infosys Recent Development Table 69. North America Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026) & (US$ Million) Table 70. North America Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032) & (US$ Million) Table 71. North America Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026) & (US$ Million) Table 72. North America Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032) & (US$ Million) Table 73. North America Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 74. North America Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026) & (US$ Million) Table 75. North America Track-and-Trace and Serialization for Drug Revenue by Country (US$ Million) & (2027-2032) Table 76. Europe Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026) & (US$ Million) Table 77. Europe Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032) & (US$ Million) Table 78. Europe Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026) & (US$ Million) Table 79. Europe Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032) & (US$ Million) Table 80. Europe Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 81. Europe Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026) & (US$ Million) Table 82. Europe Track-and-Trace and Serialization for Drug Revenue by Country (US$ Million) & (2027-2032) Table 83. China Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026) & (US$ Million) Table 84. China Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032) & (US$ Million) Table 85. China Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026) & (US$ Million) Table 86. China Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032) & (US$ Million) Table 87. Asia Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026) & (US$ Million) Table 88. Asia Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032) & (US$ Million) Table 89. Asia Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026) & (US$ Million) Table 90. Asia Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032) & (US$ Million) Table 91. Asia Track-and-Trace and Serialization for Drug Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 92. Asia Track-and-Trace and Serialization for Drug Revenue by Region (US$ Million) & (2021-2026) Table 93. Asia Track-and-Trace and Serialization for Drug Revenue by Region (US$ Million) & (2027-2032) Table 94. SAMEA Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026) & (US$ Million) Table 95. SAMEA Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032) & (US$ Million) Table 96. SAMEA Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026) & (US$ Million) Table 97. SAMEA Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032) & (US$ Million) Table 98. SAMEA Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 99. SAMEA Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026) & (US$ Million) Table 100. SAMEA Track-and-Trace and Serialization for Drug Revenue by Country (US$ Million) & (2027-2032) Table 101. Research Programs/Design for This Report Table 102. Authors List of This Report Table 103. Secondary Sources Table 104. Primary Sources List of Figures Figure 1. Track-and-Trace and Serialization for Drug Image Figure 2. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Track-and-Trace and Serialization for Drug Market Size Share 2021 VS 2025 VS 2032 Figure 4. Cloud-based Image Figure 5. On-premise Image Figure 6. Global Track-and-Trace and Serialization for Drug Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Track-and-Trace and Serialization for Drug Market Size Share 2021 VS 2025 VS 2032 Figure 8. Biopharmaceutical Image Figure 9. Chemical Pharmaceutical Image Figure 10. Global Track-and-Trace and Serialization for Drug Market Size (US$ Million) & (2021-2032) Figure 11. Global Track-and-Trace and Serialization for Drug Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Track-and-Trace and Serialization for Drug Market Share by Region: 2021 VS 2025 VS 2032 Figure 13. Global Track-and-Trace and Serialization for Drug Players Revenue Share Top 10 and Top 5 in 2025 Figure 14. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 15. Global Track-and-Trace and Serialization for Drug Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Track-and-Trace and Serialization for Drug Revenue Market Share 2021 VS 2025 VS 2032 Figure 17. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2021-2032) Figure 18. Global Track-and-Trace and Serialization for Drug Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 20. Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2021-2032) Figure 21. North America Track-and-Trace and Serialization for Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 22. North America Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032) Figure 23. North America Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032) Figure 24. North America Track-and-Trace and Serialization for Drug Revenue Share by Country (2021-2032) Figure 25. United States Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 26. Canada Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 27. Mexico Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 28. Europe Track-and-Trace and Serialization for Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032) Figure 30. Europe Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032) Figure 31. Europe Track-and-Trace and Serialization for Drug Revenue Share by Country (2021-2032) Figure 32. Germany Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 33. France Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 34. U.K. Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 35. Italy Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. Spain Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. Russia Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Netherlands Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Nordic Countries Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. China Track-and-Trace and Serialization for Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 41. China Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032) Figure 42. China Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032) Figure 43. Asia Track-and-Trace and Serialization for Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. Asia Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032) Figure 45. Asia Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032) Figure 46. Asia Track-and-Trace and Serialization for Drug Revenue Share by Region (2021-2032) Figure 47. Japan Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 48. South Korea Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 49. India Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 50. Australia Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. Taiwan Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. Southeast Asia Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. SAMEA Track-and-Trace and Serialization for Drug Revenue YoY Growth (2021-2032) & (US$ Million) Figure 54. SAMEA Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032) Figure 55. SAMEA Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032) Figure 56. SAMEA Track-and-Trace and Serialization for Drug Revenue Share by Country (2021-2032) Figure 57. Brazil Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 58. Argentina Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 59. Chile Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 60. Colombia Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Peru Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Saudi Arabia Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Israel Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. UAE Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Turkey Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Iran Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Egypt Track-and-Trace and Serialization for Drug Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Years Considered Figure 69. Research Process Figure 70. Key Executives Interviewed

Scope & coverage.

Types
  • Cloud-based
  • On-premise
Applications
  • Biopharmaceutical
  • Chemical Pharmaceutical
Companies covered
  • Bosch Packaging
  • SAP
  • Axway
  • Xyntec Inc
  • SoftGroup
  • TraceLink
  • Infosys

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Track-and-Trace and Serialization for Drug Market by Type
  3. 1.2.1 Global Track-and-Trace and Serialization for Drug Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Cloud-based
  5. 1.2.3 On-premise
  6. 1.3 Track-and-Trace and Serialization for Drug Market by Application
  7. 1.3.1 Global Track-and-Trace and Serialization for Drug Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Biopharmaceutical
  9. 1.3.3 Chemical Pharmaceutical
  10. 1.4 Assumptions and Limitations
  11. 1.5 Study Goals and Objectives
2 Track-and-Trace and Serialization for Drug Market Dynamics
  1. 2.1 Track-and-Trace and Serialization for Drug Industry Trends
  2. 2.2 Track-and-Trace and Serialization for Drug Industry Drivers
  3. 2.3 Track-and-Trace and Serialization for Drug Industry Opportunities and Challenges
  4. 2.4 Track-and-Trace and Serialization for Drug Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Track-and-Trace and Serialization for Drug Market Perspective (2021-2032)
  2. 3.2 Global Track-and-Trace and Serialization for Drug Growth Trends by Region
  3. 3.2.1 Global Track-and-Trace and Serialization for Drug Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Track-and-Trace and Serialization for Drug Market Size by Region (2021-2026)
  5. 3.2.3 Global Track-and-Trace and Serialization for Drug Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Track-and-Trace and Serialization for Drug Revenue by Players
  2. 4.1.1 Global Track-and-Trace and Serialization for Drug Revenue by Players (2021-2026)
  3. 4.1.2 Global Track-and-Trace and Serialization for Drug Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Track-and-Trace and Serialization for Drug Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Track-and-Trace and Serialization for Drug Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Track-and-Trace and Serialization for Drug Key Players Headquarters & Area Served
  7. 4.4 Global Track-and-Trace and Serialization for Drug Players, Product Type & Application
  8. 4.5 Global Track-and-Trace and Serialization for Drug Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Track-and-Trace and Serialization for Drug Market CR5 and HHI
  11. 4.6.3 2025 Track-and-Trace and Serialization for Drug Tier 1, Tier 2, and Tier 3
5 Track-and-Trace and Serialization for Drug Market Size by Type
  1. 5.1 Global Track-and-Trace and Serialization for Drug Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Track-and-Trace and Serialization for Drug Revenue by Type (2021-2032)
  3. 5.3 Global Track-and-Trace and Serialization for Drug Revenue Market Share by Type (2021-2032)
6 Track-and-Trace and Serialization for Drug Market Size by Application
  1. 6.1 Global Track-and-Trace and Serialization for Drug Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Track-and-Trace and Serialization for Drug Revenue by Application (2021-2032)
  3. 6.3 Global Track-and-Trace and Serialization for Drug Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Bosch Packaging
  2. 7.1.1 Bosch Packaging Company Information
  3. 7.1.2 Bosch Packaging Business Overview
  4. 7.1.3 Bosch Packaging Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Bosch Packaging Track-and-Trace and Serialization for Drug Product Portfolio
  6. 7.1.5 Bosch Packaging Recent Developments
  7. 7.2 SAP
  8. 7.2.1 SAP Company Information
  9. 7.2.2 SAP Business Overview
  10. 7.2.3 SAP Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  11. 7.2.4 SAP Track-and-Trace and Serialization for Drug Product Portfolio
  12. 7.2.5 SAP Recent Developments
  13. 7.3 Axway
  14. 7.3.1 Axway Company Information
  15. 7.3.2 Axway Business Overview
  16. 7.3.3 Axway Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Axway Track-and-Trace and Serialization for Drug Product Portfolio
  18. 7.3.5 Axway Recent Developments
  19. 7.4 Xyntec Inc
  20. 7.4.1 Xyntec Inc Company Information
  21. 7.4.2 Xyntec Inc Business Overview
  22. 7.4.3 Xyntec Inc Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Xyntec Inc Track-and-Trace and Serialization for Drug Product Portfolio
  24. 7.4.5 Xyntec Inc Recent Developments
  25. 7.5 SoftGroup
  26. 7.5.1 SoftGroup Company Information
  27. 7.5.2 SoftGroup Business Overview
  28. 7.5.3 SoftGroup Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  29. 7.5.4 SoftGroup Track-and-Trace and Serialization for Drug Product Portfolio
  30. 7.5.5 SoftGroup Recent Developments
  31. 7.6 TraceLink
  32. 7.6.1 TraceLink Company Information
  33. 7.6.2 TraceLink Business Overview
  34. 7.6.3 TraceLink Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  35. 7.6.4 TraceLink Track-and-Trace and Serialization for Drug Product Portfolio
  36. 7.6.5 TraceLink Recent Developments
  37. 7.7 Infosys
  38. 7.7.1 Infosys Company Information
  39. 7.7.2 Infosys Business Overview
  40. 7.7.3 Infosys Track-and-Trace and Serialization for Drug Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Infosys Track-and-Trace and Serialization for Drug Product Portfolio
  42. 7.7.5 Infosys Recent Developments
8 North America
  1. 8.1 North America Track-and-Trace and Serialization for Drug Revenue (2021-2032)
  2. 8.2 North America Track-and-Trace and Serialization for Drug Revenue by Type (2021-2032)
  3. 8.2.1 North America Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026)
  4. 8.2.2 North America Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032)
  5. 8.3 North America Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032)
  6. 8.4 North America Track-and-Trace and Serialization for Drug Revenue by Application (2021-2032)
  7. 8.4.1 North America Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026)
  8. 8.4.2 North America Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032)
  9. 8.5 North America Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032)
  10. 8.6 North America Track-and-Trace and Serialization for Drug Revenue by Country
  11. 8.6.1 North America Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026)
  13. 8.6.3 North America Track-and-Trace and Serialization for Drug Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Track-and-Trace and Serialization for Drug Revenue (2021-2032)
  2. 9.2 Europe Track-and-Trace and Serialization for Drug Revenue by Type (2021-2032)
  3. 9.2.1 Europe Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026)
  4. 9.2.2 Europe Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032)
  5. 9.3 Europe Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032)
  6. 9.4 Europe Track-and-Trace and Serialization for Drug Revenue by Application (2021-2032)
  7. 9.4.1 Europe Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026)
  8. 9.4.2 Europe Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032)
  9. 9.5 Europe Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032)
  10. 9.6 Europe Track-and-Trace and Serialization for Drug Revenue by Country
  11. 9.6.1 Europe Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026)
  13. 9.6.3 Europe Track-and-Trace and Serialization for Drug Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Track-and-Trace and Serialization for Drug Revenue (2021-2032)
  2. 10.2 China Track-and-Trace and Serialization for Drug Revenue by Type (2021-2032)
  3. 10.2.1 China Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026)
  4. 10.2.2 China Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032)
  5. 10.3 China Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032)
  6. 10.4 China Track-and-Trace and Serialization for Drug Revenue by Application (2021-2032)
  7. 10.4.1 China Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026)
  8. 10.4.2 China Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032)
  9. 10.5 China Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Track-and-Trace and Serialization for Drug Revenue (2021-2032)
  2. 11.2 Asia Track-and-Trace and Serialization for Drug Revenue by Type (2021-2032)
  3. 11.2.1 Asia Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026)
  4. 11.2.2 Asia Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032)
  5. 11.3 Asia Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032)
  6. 11.4 Asia Track-and-Trace and Serialization for Drug Revenue by Application (2021-2032)
  7. 11.4.1 Asia Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026)
  8. 11.4.2 Asia Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032)
  9. 11.5 Asia Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032)
  10. 11.6 Asia Track-and-Trace and Serialization for Drug Revenue by Country
  11. 11.6.1 Asia Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026)
  13. 11.6.3 Asia Track-and-Trace and Serialization for Drug Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Track-and-Trace and Serialization for Drug Revenue (2021-2032)
  2. 12.2 SAMEA Track-and-Trace and Serialization for Drug Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Track-and-Trace and Serialization for Drug Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Track-and-Trace and Serialization for Drug Revenue by Type (2027-2032)
  5. 12.3 SAMEA Track-and-Trace and Serialization for Drug Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Track-and-Trace and Serialization for Drug Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Track-and-Trace and Serialization for Drug Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Track-and-Trace and Serialization for Drug Revenue by Application (2027-2032)
  9. 12.5 SAMEA Track-and-Trace and Serialization for Drug Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Track-and-Trace and Serialization for Drug Revenue by Country
  11. 12.6.1 SAMEA Track-and-Trace and Serialization for Drug Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Track-and-Trace and Serialization for Drug Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Track-and-Trace and Serialization for Drug Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst